NSC |
Compound |
Enrichment |
Correlation |
NSC 695940 |
Null |
0.0280810439814505 |
0.36153331 |
NSC 726195 |
2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one |
0.0280810439814505 |
0.22745773 |
NSC 744622 |
4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide |
0.0280810439814505 |
0.13396157 |
NSC 752385 |
Null |
0.0280810439814505 |
0.28458356 |
NSC 81206 |
Null |
0.0280810439814509 |
0.47161028 |
NSC 115928 |
Benzonitrile, 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-, monoethanesulfonate (9CI) |
0.0303734648501639 |
0.41916533 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0303734648501639 |
0.3387673 |
NSC 287459 |
Cytarabine AY |
0.0303734648501639 |
0.43332393 |
NSC 336053 |
1-Piperidinesulfonamide, N-(7-amino-2-naphthalenyl)- |
0.0303734648501639 |
0.24952728 |
NSC 35580 |
Null |
0.0303734648501639 |
0.38915761 |